OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hydrogen combined with tetrandrine attenuates silica-induced pulmonary fibrosis via suppressing NF-kappaB/NLRP3 signaling pathway-mediated epithelial mesenchymal transition and inflammation
Juan Li, Ping Cui, Jing Hua, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112563-112563
Open Access | Times Cited: 6
Juan Li, Ping Cui, Jing Hua, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112563-112563
Open Access | Times Cited: 6
Showing 6 citing articles:
H3K18 lactylation-mediated SIX1 upregulation contributes to silica-induced epithelial-mesenchymal transition (EMT) of airway epithelial cells
Songtao Liu, Yiting He, Linling Jin, et al.
Toxicology (2025), pp. 154109-154109
Closed Access
Songtao Liu, Yiting He, Linling Jin, et al.
Toxicology (2025), pp. 154109-154109
Closed Access
Astragalus mongholicusbunge and Angelica sinensis botanical drug decoction mitigates lung inflammation through NOX4/TGF-β1/SMAD3 signaling
Zhifeng Yang, Yuqian Chang, Tong Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Zhifeng Yang, Yuqian Chang, Tong Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Current Status and Prospects of the Pathological Mechanisms and Therapeutic Drugs for Silicosis
艳 张
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 518-530
Closed Access
艳 张
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 518-530
Closed Access
Idiopathic pulmonary fibrosis microenvironment: Novel mechanisms and research directions
Feng Gao, Lei Pan, Wei Liu, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114653-114653
Closed Access
Feng Gao, Lei Pan, Wei Liu, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114653-114653
Closed Access
Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents
Vito D’Agnano, Fabio Perrotta, Ramona Fomez, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1391-1391
Open Access | Times Cited: 1
Vito D’Agnano, Fabio Perrotta, Ramona Fomez, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1391-1391
Open Access | Times Cited: 1
Insights on exploring the therapeutic potential and structural modification of Tetrandrine
Liang Gong, He Liu, Bo Xu, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2687-2700
Closed Access
Liang Gong, He Liu, Bo Xu, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2687-2700
Closed Access
Single-Cell Sequencing and Machine Learning Integration to Identify Candidate Biomarkers in Psoriasis: INSIG1
Xiangnan Zhou, Jingyuan Ning, Rui Cai, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 11485-11503
Open Access
Xiangnan Zhou, Jingyuan Ning, Rui Cai, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 11485-11503
Open Access
